<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr Lalchandani Labs Limited has submitted an annual disclosure to BSE clarifying that it does not qualify as a 'Large Corporate' under SEBI guidelines. The company states that its long-term borrowings as of March 31, 2026 are less than Rs. 1000 crores, which is the threshold for classification as a Large Corporate. This filing is a regulatory compliance requirement under SEBI Circular dated November 26, 2018. The disclosure is signed by Managing Director Arjan Lalchandani and filed on May 4, 2026.
Neutral filing for shareholders — the company confirms it operates with borrowings below the Rs. 1000 crore threshold, indicating conservative debt levels relative to Large Corporate classification.